C E Kearney1, D W Purdie. Show Affiliations » 1. Centre for Metabolic Bone Disease, University of Hull, Royal Hull Hospitals NHS Trust, Hull, UK.
Abstract
Mesh： See more » AgedAnimalsBreast Neoplasms/epidemiologyBreast Neoplasms/etiologyEstrogen Antagonists/administration & dosageEstrogen Antagonists/therapeutic useEstrogen Replacement Therapy/adverse effectsFemaleHumansMiddle AgedOsteoporosis, Postmenopausal/prevention & controlRaloxifene Hydrochloride/administration & dosageRaloxifene Hydrochloride/therapeutic useReceptors, Estrogen/chemistryReceptors, Estrogen/physiologySelective Estrogen Receptor ModulatorsTamoxifen/administration & dosageTamoxifen/adverse effectsTamoxifen/therapeutic use
Substances： See more » Estrogen AntagonistsReceptors, EstrogenSelective Estrogen Receptor ModulatorsTamoxifenRaloxifene Hydrochloride
Year: 1998 PMID： 11907917 DOI： 10.3109/13697139809085530
Source DB: PubMed Journal: Climacteric ISSN： 1369-7137 Impact factor: 3.005